Eribulin Mesylate
Information about Eribulin Mesylate
Eribulin Mesylate Uses
Eribulin Mesylate is used in the treatment of metastatic breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread.
How Eribulin Mesylate works
Eribulin Mesylate is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This blocks the growth cycle (cell cycle) of cancer cells and eventually kills them.
Common side effects of Eribulin Mesylate
Anemia (low number of red blood cells), Weakness, Hair loss, Nausea, Constipation, Decreased white blood cell count, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand)
Available Medicine for Eribulin Mesylate
EmbremmaEmcure Pharmaceuticals Ltd
₹195001 variant(s)
MitobulinCipla Ltd
₹13001 variant(s)
TecerisMylan Pharmaceuticals Pvt Ltd
₹318801 variant(s)
EribilinEmcure Pharmaceuticals Ltd
₹195001 variant(s)
EvairaZydus Cadila
₹209951 variant(s)
HalavenEisai Pharmaceuticals India Pvt Ltd
₹318851 variant(s)
Expert advice for Eribulin Mesylate
- Eribulin Mesylate helps treat breast cancer that has spread to other areas of the body.
- It is given by an injection into a vein (intravenously).
- It may cause dizziness and tiredness. Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for three months after you stop taking it.
- Your doctor may get regular blood tests done to monitor your blood cells and electrolyte levels during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea while taking this medicine.
- It may cause numbness, tingling or pricking sensations in your hands and feet. Inform your doctor if this bothers you.